Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ACT-One proves its flexibility

This article was originally published in Clinica

Executive Summary

Early data on Advanced Coronary Technology's ACT-One stent show that it is comparable to devices already on the market but with the advantage that it is radiopaque. A group from Toho University Hospital in Tokyo, Japan, implanted 23 ACT-One stents during a pilot study. They were successful in 90% of lesions but had to resort to using Palmaz-Schatz stents in six cases. Five stents slipped off the balloon during the study. Only three were successfully recovered.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087715

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel